Cargando…
Pristimerin Exacerbates Cellular Injury in Conditionally Reprogrammed Patient-Derived Lung Adenocarcinoma Cells by Aggravating Mitochondrial Impairment and Endoplasmic Reticulum Stress through EphB4/CDC42/N-WASP Signaling
Lung cancer is the most common and lethal malignant disease for which the development of efficacious chemotherapeutic agents remains an urgent need. Pristimerin (PRIS), a natural bioactive component isolated from various plant species in the Celastraceae and Hippocrateaceae families, has been report...
Autores principales: | Tang, Yubo, Lei, Yiyan, Huang, Shuai, Li, Zhangyan, Chen, Xiangtian, Luo, Honghe, Cheng, Chao, Chen, Jie, Zou, Xuenong, Chen, Xiao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7369684/ https://www.ncbi.nlm.nih.gov/pubmed/32733636 http://dx.doi.org/10.1155/2020/7409853 |
Ejemplares similares
-
Low Expression of EphB2, EphB3, and EphB4 in Bladder Cancer: Novel Potential Indicators of Muscular Invasion
por: Lee, Tae Ho, et al.
Publicado: (2021) -
Reelin induces EphB activation
por: Bouché, Elisabeth, et al.
Publicado: (2013) -
The Roles of EphB2 in Cancer
por: Liu, Wei, et al.
Publicado: (2022) -
Structure of the EphB6 receptor ectodomain
por: Mason, Emilia O., et al.
Publicado: (2021) -
The Differential Expression of EphB2 and EphB4 Receptor Kinases in Normal Bladder and in Transitional Cell Carcinoma of the Bladder
por: Li, Xiuqing, et al.
Publicado: (2014)